AGIO - AGIOS PHARMACEUTICALS, INC.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 42.33

Open

$ 41.98

Bid

$ 37.50 x 4

Ask

$ 43.80 x 27

Day's Range

$ 41.86 - $ 43.69

52 Week Range

$ 23.42 - $ 62.58

Volume

756,204

Average Volume

Market Cap

2.46B

Beta (5Y Monthly)

$ 1.15

PE Ratio (TTM)

$ 3.78

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2025	06-30-2025	10-Q
2	05-01-2025	03-31-2025	10-Q
3	02-13-2025	12-31-2024	10-K
4	10-31-2024	09-30-2024	10-Q
5	08-01-2024	06-30-2024	10-Q
6	05-02-2024	03-31-2024	10-Q
7	02-15-2024	12-31-2023	10-K
8	11-02-2023	09-30-2023	10-Q
9	08-03-2023	06-30-2023	10-Q
10	05-04-2023	03-31-2023	10-Q
11	02-23-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	02-24-2022	12-31-2021	10-K
16	11-03-2021	09-30-2021	10-Q
17	07-29-2021	06-30-2021	10-Q
18	04-29-2021	03-31-2021	10-Q
19	02-25-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	07-30-2020	06-30-2020	10-Q
22	04-30-2020	03-31-2020	10-Q
23	02-19-2020	12-31-2019	10-K
24	10-31-2019	09-30-2019	10-Q
25	08-01-2019	06-30-2019	10-Q
26	05-02-2019	03-31-2019	10-Q
27	02-14-2019	12-31-2018	10-K
28	11-01-2018	09-30-2018	10-Q
29	08-02-2018	06-30-2018	10-Q
30	05-04-2018	03-31-2018	10-Q
31	02-14-2018	12-31-2017	10-K
32	11-01-2017	09-30-2017	10-Q
33	08-08-2017	06-30-2017	10-Q
34	05-04-2017	03-31-2017	10-Q
35	02-16-2017	12-31-2016	10-K
36	11-03-2016	09-30-2016	10-Q
37	08-08-2016	06-30-2016	10-Q
38	05-09-2016	03-31-2016	10-Q
39	02-26-2016	12-31-2015	10-K
40	11-06-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Reported Earlier: Agios Pharmaceuticals Re...
10/17/2025 15:27:48

CAMBRIDGE, Mass., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a commercial-stage biopharmaceut...

12 Health Care Stocks Moving In Tuesday's ...
09/23/2025 12:09:16

HC Wainwright & Co. Reiterates Buy on Agio...
09/04/2025 16:04:25

HC Wainwright & Co. analyst Emily Bodnar reiterates Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and maintains $56 pri...

fda-delays-decision-on-agios-pharmaceuticals-blood-disorder-drug-for-expanded-use

FDA Delays Decision On Agios Pharmaceutica...
09/04/2025 14:49:53

Agios' Pyrukynd FDA review for thalassemia delayed to Dec. 7, 2025, after REMS submission addressing potential liver injury...

12 Health Care Stocks Moving In Thursday's...
09/04/2025 12:08:12

Agios Pharmaceuticals Announces PDUFA Goal...
09/04/2025 11:45:50

10 Health Care Stocks With Whale Alerts In...
08/21/2025 17:35:27

Saudi Food And Drug Authority Approves Agi...
08/04/2025 20:22:10

First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA's Breakthrough Medicines ProgramAgios partnered...

Agios Pharmaceuticals Says It Is Aware Of ...
08/04/2025 18:53:07

-SEC Filing

12 Health Care Stocks Moving In Monday's I...
08/04/2025 17:06:36

12 Health Care Stocks Moving In Monday's P...
08/04/2025 12:08:38

Agios Pharmaceuticals Q2 EPS $(1.93) Misse...
07/31/2025 10:32:25

Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.93) per share which missed the analyst consensus estimate ...

Earnings Scheduled For July 31, 2025
07/31/2025 08:32:50

Scotiabank Maintains Sector Outperform on ...
07/28/2025 21:29:26

Scotiabank analyst Greg Harrison maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Sector Outperform and lowers the price...

B of A Securities Maintains Buy on Agios P...
07/22/2025 16:15:51

B of A Securities analyst Greg Harrison maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and lowers the price target...

Agios, Avanmzanite Sign Agreement For Pan-...
06/09/2025 12:44:47

PYRUKYND® (mitapivat) is a first-in-class pyruvate kinase (PK) activator, approved by the European Commission for adults with P...

Agios Pharma: New Data On PK Activators, M...
05/14/2025 14:02:10

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering thera...

Scotiabank Maintains Sector Outperform on ...
05/02/2025 14:16:09

Scotiabank analyst Greg Harrison maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Sector Outperform and lowers the price...

Agios Pharmaceuticals Q1 EPS $(1.55) Beats...
05/01/2025 10:34:40

Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.55) per share which beat the analyst consensus estimate of...

Earnings Scheduled For May 1, 2025
05/01/2025 08:32:37